Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study

S Wilson Beckham, Andrea Mantsios, Noya Galai, Samuel Likindikoki, Jessie Mbwambo, Wendy Davis, Deanna Kerrigan, S Wilson Beckham, Andrea Mantsios, Noya Galai, Samuel Likindikoki, Jessie Mbwambo, Wendy Davis, Deanna Kerrigan

Abstract

Objectives: Modalities of pre-exposure prophylaxis (PrEP) for HIV prevention offer options to women at high risk including female sex workers (FSW). This study aimed to explore FSW's acceptability and preferences for oral pills, long-acting (LA) injectable and vaginal ring PrEP.

Design: Sequential, explanatory, mixed methods.

Setting: Iringa, Tanzania.

Participants: FSW aged above 18 were recruited from sex work venues using time-location sampling (n=496); HIV-uninfected (n=293) were included in this analysis. Subsequently, survey participants were recruited for in-depth interviews (n=10) and two focus group discussions (n=20).

Primary outcome measures: (1) Acceptability of PrEP (Do you personally think it would be worth it to you to take ART if it could prevent HIV?: yes/no) and (2) preference for LA injectable versus oral pills (If you personally were going to take ART to prevent HIV infection, would you prefer to take it in the form of a daily pill or an injection once every 3 months? Injection/pill).

Results: Participants were (92%) unaware of PrEP but 58% thought it would be worth it to personally take PrEP. Acceptability of PrEP was significantly associated with higher social cohesion (aOR 2.12; 95% CI 1.29 to 3.50) and STI symptoms in the past 6 months (aOR 2.52; 95% CI 1.38 to 4.62). Most (88%) preferred LA vs oral PrEP. Qualitative findings revealed generally positive reactions to all types of PrEP, and they were viewed as a welcome backup to condoms. Participants had concerns about pills (burden of daily use, stigma from clients), and the vaginal ring (fear of client noticing and becoming suspicious, fear of infertility) and overall preferred LA-PrEP (less frequent use, easy to hide, belief in higher efficacy).

Conclusions: Offering multiple formulations of PrEP within the context of community-driven HIV prevention interventions among FSW may facilitate increased uptake and adherence. LA injectable PrEP may be a particularly preferred formulation among FSW.

Trial registration number: NCT02281578.

Keywords: HIV & AIDS; PREVENTIVE MEDICINE; PUBLIC HEALTH.

Conflict of interest statement

Competing interests: Several authors (SWB, DK, AM, WD) receive funding from Viiv Healthcare. The other authors report no other conflicts of interest.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Shannon K, Crago A-L, Baral SD, et al. . The global response and unmet actions for HIV and sex workers. Lancet 2018;392:698–710. 10.1016/S0140-6736(18)31439-9
    1. Prüss-Ustün A, Wolf J, Driscoll T, et al. . Hiv due to female sex work: regional and global estimates. PLoS One 2013;8:e63476. 10.1371/journal.pone.0063476
    1. Chersich MF, Luchters S, Ntaganira I, et al. . Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services. J Int AIDS Soc 2013;16:17980. 10.7448/IAS.16.1.17980
    1. Beckham SW, Shembilu CR, Brahmbhatt H, et al. . Female sex workers' experiences with intended pregnancy and antenatal care services in southern Tanzania. Stud Fam Plann 2015;46:55–71. 10.1111/j.1728-4465.2015.00015.x
    1. Layer EH, Brahmbhatt H, Beckham SW, et al. . "I pray that they accept me without scolding:" experiences with disengagement and re-engagement in HIV care and treatment services in Tanzania. AIDS Patient Care STDS 2014;28:483–8. 10.1089/apc.2014.0077
    1. Fonner VA, Dalglish SL, Kennedy CE, et al. . Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS 2016;30:1973–83. 10.1097/QAD.0000000000001145
    1. McGillen JB, Anderson S-J, Hallett TB. Prep as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa. J Int AIDS Soc 2016;19:21104. 10.7448/IAS.19.7.21104
    1. Mitchell KM, Prudden HJ, Washington R, et al. . Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study. J Int AIDS Soc 2016;19:2–10. 10.7448/IAS.19.1.20942
    1. Baeten JM, Palanee-Phillips T, Brown ER, et al. . Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med 2016;375:2121–32. 10.1056/NEJMoa1506110
    1. Murray MI, Markowitz M, Frank I. Tolerability and acceptability of Cabotegravir La injection: results from ECLAIR study. Seattle: CROI, 2016.
    1. Delany-Moretlwe S, Mullick S, Eakle R, et al. . Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception. Curr Opin HIV AIDS 2016;11:87–93. 10.1097/COH.0000000000000221
    1. Marrazzo JM, Ramjee G, Richardson BA, et al. . Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med 2015;372:509–18. 10.1056/NEJMoa1402269
    1. Van Damme L, Corneli A, Ahmed K, et al. . Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367:411–22. 10.1056/NEJMoa1202614
    1. Haire BG. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative review. Hiv Aids 2015;7:241–9. 10.2147/HIV.S72419
    1. Luecke EH, Cheng H, Woeber K, et al. . Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study. J Int AIDS Soc 2016;19:1–9. 10.7448/IAS.19.1.20875
    1. Eisingerich AB, Wheelock A, Gomez GB, et al. . Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One 2012;7:e28238. 10.1371/journal.pone.0028238
    1. Terris-Prestholt F, Hanson K, MacPhail C, et al. . How much demand for new HIV prevention technologies can we really expect? results from a discrete choice experiment in South Africa. PLoS One 2013;8:e83193. 10.1371/journal.pone.0083193
    1. Amico KR, Stirratt MJ. Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence. Clin Infect Dis 2014;59 Suppl 1:S55–60. 10.1093/cid/ciu266
    1. Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav 2014;18:195–216. 10.1007/s10461-013-0560-7
    1. Glasgow RE, Vinson C, Chambers D, et al. . National Institutes of health approaches to dissemination and implementation science: current and future directions. Am J Public Health 2012;102:1274–81. 10.2105/AJPH.2012.300755
    1. Bekker L-G, Johnson L, Cowan F, et al. . Combination HIV prevention for female sex workers: what is the evidence? Lancet 2015;385:72–87. 10.1016/S0140-6736(14)60974-0
    1. Cáceres CF, O'Reilly KR, Mayer KH, et al. . Prep implementation: moving from trials to policy and practice. J Int AIDS Soc 2015;18:20222. 10.7448/IAS.18.4.20222
    1. Cowan FM, Delany-Moretlwe S. Promise and pitfalls of pre-exposure prophylaxis for female sex workers. Curr Opin HIV AIDS 2016;11:27–34. 10.1097/COH.0000000000000215
    1. Cowan FM, Delany-Moretlwe S, Sanders EJ, et al. . Prep implementation research in Africa: what is new? J Int AIDS Soc 2016;19:21101. 10.7448/IAS.19.7.21101
    1. Venter WDF, Cowan F, Black V, et al. . Pre-exposure prophylaxis in southern Africa: feasible or not? J Int AIDS Soc 2015;18:19979. 10.7448/IAS.18.4.19979
    1. Global Network of Sex Work Projects . Global consultation: PreP and early treatment as HIV prevention strategies, 2014.
    1. Quaife M, Eakle R, Cabrera M, et al. . Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in gauteng province, South Africa: a protocol for a discrete choice experiment. BMJ Open 2016;6:e010682. 10.1136/bmjopen-2015-010682
    1. Kerrigan D, Donastorg Y, Barrington C, et al. . Assessing and addressing social determinants of HIV among female sex workers in the dominican republic and Tanzania through community empowerment-based responses. Curr HIV/AIDS Rep 2020;17:88–96. 10.1007/s11904-020-00485-3
    1. Kerrigan D, Kennedy CE, Morgan-Thomas R, et al. . A community empowerment approach to the HIV response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up. Lancet 2015;385:172–85. 10.1016/S0140-6736(14)60973-9
    1. Wirtz AL, Pretorius C, Beyrer C, et al. . Epidemic impacts of a community empowerment intervention for HIV prevention among female sex workers in generalized and concentrated epidemics. PLoS One 2014;9:e88047-e. 10.1371/journal.pone.0088047
    1. Cowan FM, Reza-Paul S, Ramaiah M, et al. . Strategies to promote the meaningful involvement of sex workers in HIV prevention and care. Curr Opin HIV AIDS 2019;14:401–8. 10.1097/COH.0000000000000562
    1. Creswell JW, Clark VLP. Designing and conducting mixed methods research. 2nd. Los Angeles: Sage Publications, Inc, 2011.
    1. Kerrigan D, Mbwambo J, Likindikoki S, et al. . Project Shikamana: baseline findings from a community empowerment-based combination HIV prevention trial among female sex workers in Iringa, Tanzania. J Acquir Immune Defic Syndr 2017;74 Suppl 1:S60–8. 10.1097/QAI.0000000000001203
    1. Kerrigan D, Telles P, Torres H, et al. . Community development and HIV/STI-related vulnerability among female sex workers in rio de Janeiro, Brazil. Health Educ Res 2008;23:137–45. 10.1093/her/cym011
    1. Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS One 2020;15:e0232076. 10.1371/journal.pone.0232076
    1. Poon AN, Han L, Li Z, et al. . Acceptability and willingness of HIV pre-exposure prophylaxis amongst female sex workers in China. AIDS Care 2019;31:1555–64. 10.1080/09540121.2019.1612001
    1. Footer KHA, Lim S, Rael CT, et al. . Exploring new and existing PreP modalities among female sex workers and women who inject drugs in a U.S. City. AIDS Care 2019;31:1207–13. 10.1080/09540121.2019.1587352
    1. Swendeman D, Basu I, Das S, et al. . Empowering sex workers in India to reduce vulnerability to HIV and sexually transmitted diseases. Soc Sci Med 2009;69:1157–66. 10.1016/j.socscimed.2009.07.035
    1. Blankenship KM, West BS, Kershaw TS, et al. . Power, community mobilization, and condom use practices among female sex workers in Andhra Pradesh, India. AIDS 2008;22 Suppl 5:S109–16. 10.1097/01.aids.0000343769.92949.dd
    1. Blanchard AK, Mohan HL, Shahmanesh M, et al. . Community mobilization, empowerment and HIV prevention among female sex workers in South India. BMC Public Health 2013;13:234. 10.1186/1471-2458-13-234
    1. Reza-Paul S, Beattie T, Syed HUR, et al. . Declines in risk behaviour and sexually transmitted infection prevalence following a community-led HIV preventive intervention among female sex workers in Mysore, India. AIDS 2008;22 Suppl 5:S91–100. 10.1097/01.aids.0000343767.08197.18
    1. Cornish F, Shukla A, Banerji R, Persuading BR. Persuading, protesting and exchanging favours: strategies used by Indian sex workers to WIN local support for their HIV prevention programmes. AIDS Care 2010;22 Suppl 2:1670–8. 10.1080/09540121.2010.521545
    1. Reza-Paul S, Lazarus L, Jana S, et al. . Community inclusion in PreP demonstration projects: lessons for scaling up. Gates Open Res 2019;3:1504. 10.12688/gatesopenres.13042.1
    1. Griffin JB, Ridgeway K, Montgomery E, et al. . Vaginal ring acceptability and related preferences among women in low- and middle-income countries: a systematic review and narrative synthesis. PLoS One 2019;14:e0224898. 10.1371/journal.pone.0224898
    1. Woodsong C, Holt JDS. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy. Adv Drug Deliv Rev 2015;92:146–54. 10.1016/j.addr.2015.02.004
    1. Giguère K, Béhanzin L, Guédou FA, et al. . Prep use among female sex workers: no evidence for risk compensation. J Acquir Immune Defic Syndr 2019;82:257–64. 10.1097/QAI.0000000000002134
    1. Eakle R, Gomez GB, Naicker N, et al. . Hiv pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project. PLoS Med 2017;14:e1002444. 10.1371/journal.pmed.1002444
    1. Bowring AL, Ampt FH, Schwartz S, et al. . Hiv pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind. J Int AIDS Soc 2020;23:e25442. 10.1002/jia2.25442
    1. Woodsong C, Musara P, Chandipwisa A, et al. . Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa. BJOG 2014;121 Suppl 5:45–52. 10.1111/1471-0528.12875
    1. International Partnership for Microbicides . Dapivirine-Contraceptive ring. Available:
    1. Hendrickson ZM, Leddy AM, Galai N, et al. . Work-related mobility and experiences of gender-based violence among female sex workers in Iringa, Tanzania: a cross-sectional analysis of baseline data from project Shikamana. BMJ Open 2018;8:e022621. 10.1136/bmjopen-2018-022621
    1. HPTN 084 study demonstrates superiority of cab La to oral TDF/FTC for the prevention of HIV, 2020. [Accessed 09 Nov 2020].
    1. ViiV healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women, 2020. [Accessed 09 Nov 2020].
    1. Global Network of Sex Work Projects . Prep Briefing paper; 2016.

Source: PubMed

3
S'abonner